Lalu loyalist Ram Kripal quits all party posts over ticket row

March 8, 2014

Ram_KripalNew Delhi/Patna, Mar 8: In a jolt to RJD, senior party leader Ram Kripal Yadav today quit from all party posts over denial of ticket from Patliputra Lok Sabha seat and said he was keeping all his options open.

Yadav, a close aide of RJD chief Lalu Prasad whose daughter Misa Bharti has been given Patliputra seat, accused the party of being more interested in serving "family justice" than social justice for which it was formed.

Yadav, currently a Rajya Sabha member and a three-time Lok Sabha MP from Patna, said he has decided to quit party posts with a "heavy heart" and his written resignation will follow. He, however said he was still in the party as of now and has not quit from Rajya Sabha.

Yadav is secretary-general of RJD and a member of the party's parliamentary board. There is speculation that he may join BJP to contest from the seat.

"I am very attached to the party and its workers. I think, the way Misa came to me yesterday, it was an 'emotional atyachar' or a 'political stunt' which was used against a simple person like me," Yadav told reporters in Delhi referring to Bharti's visit to his home here and staying put for five hours in a bid to persuade him.

Bharti, who returned to Patna, today hit back at Yadav saying it was he who was indulging in "emotional blackmail" and "nautanki" (drama) and that she was firm on contesting the seat.

Yadav refrained from commenting on the possibility of joining another party or contesting Lok Sabha elections. "All options are open. I am mulling these issues. Other decisions will be taken later," Yadav said.

He said that despite conveying his willingness to fight the Lok Sabha elections a long time back to his party national president, such a decision was taken.

"I wanted to fight Lok Sabha elections. This was the demand of the workers as well as that of the people. One year back, I had conveyed my feelings to the party national president. I had said even if 'Madam'

becomes candidate, it will be ok with me. But the decision was taken. Despite that I did not utter a single word against the party," Yadav said.

Lalu Prasad has been grappling with dissent in the party ahead of Lok Sabha election. 13 RJD MLAs had resigned from the party last month but later nine had attended the legislature party meeting.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

New Delhi, Mar 29: The total number of COVID-19 positive cases rose to 1024 in the country, said Ministry of Health and Family Welfare on Sunday.

"The total number of COVID-19 positive cases rise to 1024 in India including 901 active cases, 96 cured/discharged/migrated people and 27 deaths," Ministry of Health and Family Welfare said.
Prime Minister Narendra Modi had on Tuesday announced a 21-day lockdown to stem the spread of COVID-19, which has left thousands dead around the world.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 11,2020

New Delhi, May 11: With an increase of 4,213 cases in the past 24 hours, India's COVID-19 count reached 67,152 on Monday, according to the Union Ministry of Health and Family Welfare.

The number of active cases in the country rose to 44,029, while 20,916 patients have been cured and discharged and one has migrated, according to the Ministry.

The number of deaths in the country due to the infection reached 2,206 on Sunday.

Maharashtra, with 22,171 confirmed cases is the worst-affected due to the infection so far and is followed by Gujarat with 8,194 cases.

However, Tamil Nadu surpassed the national capital in total coronavirus cases numbers. Delhi has 6,923 reported cases while Tamil Nadu has 7,204 confirmed cases.

Maximum deaths due to coronavirus have so far been recorded in Maharashtra (832), followed by Gujarat which has toll of 493.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.